Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors
- PMID: 29949632
- PMCID: PMC6021089
- DOI: 10.1371/journal.pone.0199557
Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors
Abstract
Background: Penile carcinoma (PC) is a rare, highly mutilating disease, common in developing countries. The evolution of penile cancer includes at least two independent carcinogenic pathways, related or unrelated to HPV infection.
Objectives: To estimate the prevalence, identify HPV genotypes, and correlate with clinicopathological data on penile cancer.
Methods: A retrospective cohort study involving 183 patients with PC undergoing treatment in a referral hospital in Goiânia, Goiás, in Midwestern Brazil, from 2003 to 2015. Samples containing paraffin embedded tumor fragments were subjected to detection and genotyping by INNO-LiPA HPV. The clinicopathological variables were subjected to analysis with respect to HPV positivity and used prevalence ratio (PR), adjusted prevalence ratio (PRa) and 95% confidence interval (CI) as statistical measures.
Results: The prevalence of HPV DNA in PC was 30.6% (95% CI: 24.4 to 37.6), high-risk HPV 24.9% (95% CI: 18.9 to 31.3), and 62.5% were HPV 16. There was a statistical association between the endpoints HPV infection and HPV high risk, and the variable tumor grade II-III (p = 0.025) (p = 0.040), respectively. There was no statistical difference in disease specific survival at 10 years between the HPV positive and negative patients (p = 0.143), and high and low risk HPV (p = 0.325).
Conclusions: The prevalence of HPV infection was 30.6%, and 80.3% of the genotypes were identified as preventable by anti-HPV quadrivalent or nonavalent vaccine. HPV infections and high-risk HPV were not associated with penile carcinoma prognosis in this study.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Role of Human Papillomavirus in Penile Carcinomas Worldwide.Eur Urol. 2016 May;69(5):953-61. doi: 10.1016/j.eururo.2015.12.007. Epub 2016 Jan 5. Eur Urol. 2016. PMID: 26762611
-
Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome.J Urol. 2015 Feb;193(2):526-31. doi: 10.1016/j.juro.2014.08.087. Epub 2014 Aug 21. J Urol. 2015. PMID: 25150641
-
Human papillomavirus genotypes and P16INK4A expression in squamous penile carcinoma in Mexican patients.BMC Infect Dis. 2019 Dec 19;19(1):1068. doi: 10.1186/s12879-019-4696-6. BMC Infect Dis. 2019. PMID: 31856740 Free PMC article.
-
Human papillomavirus prevalence and type distribution in penile carcinoma.J Clin Pathol. 2009 Oct;62(10):870-8. doi: 10.1136/jcp.2008.063149. Epub 2009 Aug 25. J Clin Pathol. 2009. PMID: 19706632 Review.
-
The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas.Semin Diagn Pathol. 2012 May;29(2):67-71. doi: 10.1053/j.semdp.2011.09.001. Semin Diagn Pathol. 2012. PMID: 22641955 Review.
Cited by
-
HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights.Pathogens. 2024 Sep 18;13(9):809. doi: 10.3390/pathogens13090809. Pathogens. 2024. PMID: 39339000 Free PMC article. Review.
-
Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2021 May 1;22(5):1351-1364. doi: 10.31557/APJCP.2021.22.5.1351. Asian Pac J Cancer Prev. 2021. PMID: 34048162 Free PMC article.
-
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis.Front Oncol. 2022 Jun 29;12:926692. doi: 10.3389/fonc.2022.926692. eCollection 2022. Front Oncol. 2022. PMID: 35847850 Free PMC article.
-
Presence of HPV with overexpression of p16INK4a protein and EBV infection in penile cancer-A series of cases from Brazil Amazon.PLoS One. 2020 May 6;15(5):e0232474. doi: 10.1371/journal.pone.0232474. eCollection 2020. PLoS One. 2020. PMID: 32374757 Free PMC article.
-
The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic Review.Cancers (Basel). 2023 Jul 21;15(14):3713. doi: 10.3390/cancers15143713. Cancers (Basel). 2023. PMID: 37509374 Free PMC article. Review.
References
-
- Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer C. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27(2):141–50. doi: 10.1007/s00345-008-0302-z - DOI - PubMed
-
- Morrison BF. Risk factors and prevalence of penile cancer. West Indian Med J. 2014. October;63(6):559–560. doi: 10.7727/wimj.2015.381 - DOI - PMC - PubMed
-
- Spiess PE, Dhillon J, Baumgarten AS, Johnstone PA, Giuliano AR. Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies. CA Cancer J Clin. 2016. June 17; 66:481–95. doi: 10.3322/caac.21354 - DOI - PubMed
-
- Costa S, Rodrigues R, Barbosa L, Silva JO, Brandão JOC, Medeiros CSQ. Câncer de pênis: Epidemiologia e estratégias de prevenção. Cadernos de graduação—Ciências biológicas e da saúde facipe. 2013;1(2):23–33. Portuguese.
-
- Favorito LA, Nardi AC, Ronalsa M, Zequi SC, Sampaio FJ, Glina S. Epidemiologic study on penile cancer in brazil. Int Braz J Urol. 2008. Sep-Oct;34(5):587–91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials